New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval (Q44518215)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 July 2007
edit
Language Label Description Also known as
English
New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval
scientific article published on 24 July 2007

    Statements

    New antirheumatic drugs: any real added value? A critical overview of regulatory criteria for their marketing approval (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit